Interestingly, tumorigenic K-Pα(+)S KS were able to continue proliferating after KSHV lytic reactivation and after KSHV in vivo lytic switch in Matrigel-plugs, in spite of enhanced KSHV oncogene expression. The gene discussed is LRP1; the disease is Kaposi's sarcoma.